MK2 Inhibition Induces p53-Dependent Senescence in Glioblastoma Cells.

Autor: Phoa AF; School of Medical Sciences, Charles Perkins Centre and Faculty of Medicine and Health, The University of Sydney, NSW 2006, Australia., Recasens A; School of Medical Sciences, Charles Perkins Centre and Faculty of Medicine and Health, The University of Sydney, NSW 2006, Australia., Gurgis FMS; School of Medical Sciences, Charles Perkins Centre and Faculty of Medicine and Health, The University of Sydney, NSW 2006, Australia., Betts TA; School of Medical Sciences, Charles Perkins Centre and Faculty of Medicine and Health, The University of Sydney, NSW 2006, Australia., Menezes SV; School of Medical Sciences, Charles Perkins Centre and Faculty of Medicine and Health, The University of Sydney, NSW 2006, Australia., Chau D; Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia.; Department of Medical Biology, University of Melbourne, Parkville, Victoria 3050, Australia., Nordfors K; Department of Pediatrics, Tampere University Hospital, 33521 Tampere, Finland.; Tampere Center for Child Health Research, University of Tampere, 33014 Tampere, Finland.; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada., Haapasalo J; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.; Department of Pathology, Fimlab Laboratories, Tampere University Hospital, FI-33521 Tampere, Finland., Haapasalo H; Department of Pathology, Fimlab Laboratories, Tampere University Hospital, FI-33521 Tampere, Finland., Johns TG; Oncogenic Signalling Laboratory, Telethon Kids Institute, Perth Children's Hospital, 15 Hospital Avenue, Nedlands, WA 6009, Australia., Stringer BW; QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, QLD 4006, Australia., Day BW; QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, QLD 4006, Australia., Buckland ME; School of Medical Sciences, Charles Perkins Centre and Faculty of Medicine and Health, The University of Sydney, NSW 2006, Australia.; Brain and Mind Research Institute, The University of Sydney, NSW 2006, Australia., Lalaoui N; Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia.; Department of Medical Biology, University of Melbourne, Parkville, Victoria 3050, Australia., Munoz L; School of Medical Sciences, Charles Perkins Centre and Faculty of Medicine and Health, The University of Sydney, NSW 2006, Australia.

Publikováno v: Cancers [Cancers (Basel)] 2020 Mar 11; Vol. 12 (3). Date of Electronic Publication: 2020 Mar 11.

The potential therapeutic effect of phosphodiesterase 5 inhibitors in the acute ischemic stroke (AIS).

Autor: AlRuwaili, Raed, Al-kuraishy, Hayder M., Alruwaili, Mubarak, Khalifa, Amira Karam, Alexiou, Athanasios, Papadakis, Marios, Saad, Hebatallah M., Batiha, Gaber El-Saber

Publikováno v: Molecular & Cellular Biochemistry; May2024, Vol. 479 Issue 5, p1267-1278, 12p

MAPK-Activated Protein Kinases: Servant or Partner?

Autor: Ronkina, Natalia, Gaestel, Matthias

Publikováno v: Annual Review of Biochemistry; 2022, Vol. 91 Issue 3, p505-540, 36p

Adipocyte-specific deletion of HuR induces spontaneous cardiac hypertrophy and fibrosis.

Autor: Guarnieri, Adrienne R., Anthony, Sarah R., Gozdiff, Anamarie, Green, Lisa C., Fleifil, Salma M., Slone, Sam, Nieman, Michelle L., Alam, Perwez, Benoit, Joshua B., Owens, A. Phillip, Kanisicak, Onur, Tranter, Michael

Publikováno v: American Journal of Physiology: Heart & Circulatory Physiology; Jul2021, Vol. 321 Issue 1, pH228-H241, 14p

Therapeutic potential of Hsp27 in neurological diseases.

Autor: Venugopal, Anila¹ (AUTHOR), Sundaramoorthy, Kasthuri² (AUTHOR), Vellingiri, Balachandar¹ (AUTHOR) geneticbala@buc.edu.in

Publikováno v: Egyptian Journal of Medical Human Genetics. 11/5/2019, Vol. 20 Issue 1, pN.PAG-N.PAG. 1p.